Evaluation of chemopreventive activity of glutamine by the comet and the micronucleus assay in mice's peripheral blood

Environmental Toxicology and Pharmacology

Volumn 28, Issue 1, 2009, Pages 120-124

  Oliveira, Rodrigo Juliano ^a,b,c   Baise, Évelyn ^a   Mauro, Mariana de Oliveira ^a   Pesarini, João Renato ^a   Matuo, Renata ^b   Silva, Ariane Fernanda da ^b   Ribeiro, Lúcia Regina ^c   Mantovani, Mário Sérgio ^b  

^a Centro Universitario Filadelfia UniFil   (Brazil)

^b STATE UNIVERSITY OF LONDRINA   (Brazil)

^c SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Chemoprevention; Cisplatin; Comet; Glutamine; Micronucleus

Indexed keywords

CISPLATIN; GLUTAMINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMOPROPHYLAXIS; COMET ASSAY; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; GENOTOXICITY; MALE; MICRONUCLEUS TEST; MOUSE; MUTAGENIC ACTIVITY; NONHUMAN; PRIORITY JOURNAL; SWISS WEBSTER MOUSE;

MUS;

EID: 67349094547     PISSN: 13826689     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.etap.2009.03.008     Document Type: Article

References (28)

1. Albertini S.M., and Ruiz M.A. O papel da glutamina na terapia nutricional do transplante de medula óssea. Rev. Bras. Hematol. Hemoter. 23 (2001) 41-47
2. Antunes L.M.G., and Bianchi L.P. Antioxidantes da dieta como inibidores da nefrotoxicidade induzida pelo antitumoral cisplatina. Rev. Nutr. 17 (2004) 89-96
3. Barbosa R.C.C., Guimarães S.B., Vasconcelos P.R.C., Chaves C.R., and Vasconcelos P.R.L. Efeitos metabólicos da glutamina em ratos submetidos à queimadura por água fervente. Acta Cir. Bras. 18 (2003) 537-541
4. De Flora S. Mechanisms of inhibitors of mutagenesis and carcinogenesis. Mutat. Res. 402 (1998) 151-158
5. Diestel C.F., Lopes-Paulo F., Marques R.G., Horsts N.L., and Caetano C.E.R. Efeito da suplementação oral de l-glutamina na parede colônica de ratos submetidos à irradiação abdominal. Acta Cir. Bras. 20 (2005) 94-100
6. Dusse L.M.S., Vieria L.M., and Carvalho M.G. Nitric oxide revision. J. Bras. Patol. Med. Lab. 39 (2003) 343-350
7. Elsendoorn T.J., Weijl N.I., Mithoe S., Zwinderman A.H., Van Dam F., De Zwarf F.A., Tates A.D., and Osanto S. Chemotherapy-induced chromosomal damage in peripheral blood lymphocytes of cancer patients supplemented with antioxidants or placebo. Mutat. Res. 498 (2001) 145-158
8. Flora F.R., and Zilberstein B. Óxido nítrico: o simples mensageiro percorrendo a complexidade. Metabolismo, síntese e funções. Rev. Ass. Med. Bras. 43 (2000) 265-271
9. Furst P., Pogan K., and Stehle P. Glutamine dipeptides in clinical nutrition. Nutrition 13 (1997) 731-737
10. Grüter A., Friederich U., and Würgler F.E. Antimutagenic effects of mushrooms. Mutat. Res. 231 (1990) 243-249
11. Hartman P.E., and Shankel D.M. Antimutagens and anticarcinogens: a survey of putative interceptor molecules. Environ. Mol. Mutagen. 15 (1990) 145-182
12. Hayashi M., Morita T., Kodama Y., Sofuni T., and Ishidate Jr. M. The micronucleus assay with mouse peripheral blood reticulocytes using acridine orange-coated slides. Mutat. Res. 245 (1990) 245-249
13. Jordão-Júnior A.A., Chiarello P.G., Bernardes M.S.M., and Vannucchi H. Peroxidação lipídica e etanol: papel da glutationa reduzida e da vitamina E. Medicina 31 (1998) 434-449
14. Kada T., Inoue T., and Namiki N. Environmental desmutagens and antidesmutagens. In: Klekowski E.J. (Ed). Environ. Mutag. Plant Biol. (1982), Praeger, New York 137-151
15. Kada T., and Shimoi K. Desmutagens and bio-antimutagens: their modes of action. Bio Essays 7 (1987) 113-115
16. Kelloff G.J., Crowell J.A., Steele V.E., Lubet R.A., Boone C.W., Malone W.A., Haw E.T., Lieberman R., Lawrence J.A., Kopelovich L., Ali T., Viner J.L., and Sigman C.C. Progress in cancer chemoprevention. Ann. N. Y. Acad. Sci. 889 (1999) 1-13
17. Kleiner, S.M., 1997. Defense plants: foods that fight disease. 28 September 1997. Available in http://www.physsportsmed.com. Access in 28 September 1998.
18. Konturek S.K., and Konturek P.C. Role of nitric oxide in the digestive system. Digestion 56 (1995) 1-13
19. Mora L.O., Antunes L.M., Francescato H.D.C., and Bianchi M.L.P. The effects of oral glutamine on cisplatin-induced genotoxicity in Wistar rat bone marrow cells. Mutat. Res. 518 (2002) 65-70
20. Mora L.O., Antunes L.M., Francescato H.D.C., and Bianchi M.L.P. The effects of oral glutamine on cisplatin-induced nephrotoxicity in rats. Pharmacol. Res. 47 (2003) 517-522
21. Neu J., Roig J.C., Meetze W.H., Veerman M., Carter C., Milisaps M., Bowling D., Dallas M.J., Sleasman J., Knight T., and Auestad N. Enteral glutamine supplementation for very low birth weight infants decreases morbidity. J. Pediatr. 131 (1997) 691-699
22. Oliveira R.J., Ribeiro L.R., Silva A.F., Matuo R., and Mantovani M.S. Evaluation of antimutagenic activity and HTC cell lines using the micronucleus test. Toxicol. In Vitro 20 (2006) 1225-1233
23. Pacífico S.L., Leite H.P., and Carvalho W.B. A suplementação de glutamina é benéfica em crianças com doenças graves. Rev. Nutr. 18 (2005) 95-104
24. Savy G.K. Enteral glutamine supplementation: clinical review and practical guidelines. Nutr. Clin. Pract. 12 (1997) 259-262
25. Waters M.D., Brady A.L., Stack H.F., and Brockman H.E. Antimutagenicity profiles for some model compounds. Mutat. Res. 238 (1990) 57-85
26. Weijl N.I., Hopman G.D., Wipkink-Bakker A., Lentjes E.G.W.M., Berger H.M., Cleton F.J., and Osanto S. Cisplatin combination chemotherapy induces a fall in plasma antioxidants of cancer patients. Ann. Oncol. 9 (1998) 131-137
27. Ziegler T.R., Benfell K., Smith R.J., Young L.S., Brown E., Ferrari-Baliviera E., Lowe D.K., and Wilmore D.W. Safety and metabolic effects of l-glutamine administration in humans. J. Parenter. Enter. Nutr. 14 (1990) 1375-1465
28. Ziegler T.R., Young L.S., Benfell K., Scheltinga M., Hortos K., Bye R., Morrow F.D., Jacobs D.O., Smith R.J., and Antin J.H. Clinical and metabolic efficacy of glutamine-supplemented parenteral nutrition after bone marrow transplantation. Ann. Int. Med. 116 (1992) 821-828